Astefanos Al-Dalakta, MD (@astefanosmd) 's Twitter Profile
Astefanos Al-Dalakta, MD

@astefanosmd

Internal Medicine resident @ccf_imchiefs | MD’22 @lebamericanuni

ID: 1572973559034650626

calendar_today22-09-2022 15:38:24

202 Tweet

445 Takipçi

537 Takip Edilen

Chadi Tabaja (@chadi_97ep) 's Twitter Profile Photo

Proud to share our latest work JACC Journals lead by Ashraf Alzahrani, MD Outcomes of Concomitant AF Ablation and Left Atrial Appendage Closure: A Retrospective Single-Center Experience Grateful for the mentorship Oussama Wazni Samir Kapadia Cleveland Clinic Heart, Vascular & Thoracic sciencedirect.com/science/articl…

Chadi Tabaja (@chadi_97ep) 's Twitter Profile Photo

Highlight of the week, humbled to receive the Inpatient Intern of the Month award! Grateful to be part of an incredible program that fosters growth and excellence while delivering world-class care. Cleveland Clinic IM Cleveland Clinic

Highlight of the week, humbled to receive the Inpatient Intern of the Month award!
Grateful to be part of an incredible program that fosters growth and excellence while delivering world-class care. 
<a href="/CCF_IMCHIEFS/">Cleveland Clinic IM</a> <a href="/ClevelandClinic/">Cleveland Clinic</a>
Tom Mihaljevic (@tommihaljevicmd) 's Twitter Profile Photo

Newsweek has ranked Cleveland Clinic as the #2 hospital in the world. This recognition is a reflection of our caregivers, who form the heart and soul of our organization. Their dedication to excellence and compassion are the pillars of our care. More: bit.ly/43n8n05

NEJM (@nejm) 's Twitter Profile Photo

In the Advance-HTN phase 2b trial of the aldosterone synthase inhibitor lorundrostat in participants with uncontrolled hypertension, lorundrostat was associated with greater reductions in blood pressure than placebo. Full trial results: nej.md/4ipbCIf

In the Advance-HTN phase 2b trial of the aldosterone synthase inhibitor lorundrostat in participants with uncontrolled hypertension, lorundrostat was associated with greater reductions in blood pressure than placebo. Full trial results: nej.md/4ipbCIf